Correlation Between Acurx Pharmaceuticals and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acurx Pharmaceuticals and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acurx Pharmaceuticals and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acurx Pharmaceuticals LLC and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Acurx Pharmaceuticals and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acurx Pharmaceuticals with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acurx Pharmaceuticals and Reviva Pharmaceuticals.
Diversification Opportunities for Acurx Pharmaceuticals and Reviva Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Acurx and Reviva is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Acurx Pharmaceuticals LLC and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Acurx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acurx Pharmaceuticals LLC are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Acurx Pharmaceuticals i.e., Acurx Pharmaceuticals and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acurx Pharmaceuticals and Reviva Pharmaceuticals
Given the investment horizon of 90 days Acurx Pharmaceuticals LLC is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Acurx Pharmaceuticals LLC is 1.5 times less risky than Reviva Pharmaceuticals. The stock trades about -0.21 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Reviva Pharmaceuticals Holdings on September 15, 2024 and sell it today you would earn a total of 144.00 from holding Reviva Pharmaceuticals Holdings or generate 123.08% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Acurx Pharmaceuticals LLC vs. Reviva Pharmaceuticals Holding
Performance |
Timeline |
Acurx Pharmaceuticals LLC |
Reviva Pharmaceuticals |
Acurx Pharmaceuticals and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acurx Pharmaceuticals and Reviva Pharmaceuticals
The main advantage of trading using opposite Acurx Pharmaceuticals and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acurx Pharmaceuticals position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Valuation Check real value of public entities based on technical and fundamental data |